Medical Imaging (MEDD) 10-K 14 Apr 16 2015 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2015	Apr. 06, 2016	Jun. 30, 2015
Document And Entity Information
Entity Registrant Name	MEDICAL IMAGING CORP.
Entity Central Index Key	1,370,804
Document Type	10-K
Document Period End Date	Dec. 31, 2015
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Smaller Reporting Company
Entity Public Float			$ 772,913
Entity Common Stock, Shares Outstanding		25,561,481
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2,015

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Current Assets
Cash and Cash Equivalents	$ 109,914	$ 188,206
Accounts Receivable
Accounts Receivable - Direct Billings	708,479	541,298
Accounts Receivable - Third Party Billings (Florida Operation	503,206	375,259
Allowance for Doubtful Accounts - Direct Billings	(56,475)	(64,673)
Allowance for Doubtful Accounts - Third Party Billings (Florida Operations	(275,000)	0
Accounts Receivable, net	880,210	851,884
Prepaid Expenses	19,204	24,165
Total Current Assets	1,009,328	1,064,255
Property and Equipment
Equipment	3,454,718	3,402,671
Less: Accumulated Depreciation	(998,224)	(463,977)
Total Property and Equipment, net	2,456,494	2,938,694
Goodwill	1,977,670	1,977,670
Other Assets
Deposits	11,764	12,463
Loan Receivable	0	1,497
Total Other Assets	11,764	13,960
TOTAL ASSETS	5,455,256	5,994,579
Current Liabilities
Accounts Payable	1,212,430	624,141
Accrued Liabilities	580,336	311,547
Obligations Under Capital Lease, short term portion	205,740	189,923
Promissory Notes, short term portion	409,789	134,999
Royalty Financing, short term portion	106,141	102,219
Convertible Notes, net short term portion	156,425	54,263
Total Current Liabilities	2,670,861	1,417,092
Long Term Liabilities
Obligations Under Capital Lease, long term portion	267,146	459,853
Royalty Financing, long term portion	1,828,960	1,902,698
Convertible Notes, net, long term portion	2,267,575	2,332,708
Total Long Term Liabilities	4,363,681	4,695,259
Total Liabilities	7,034,542	6,112,351
Stockholders' Deficit
Preferred Stock	0	0
Common Stock	25,392	23,947
Additional Paid-In Capital	2,034,758	1,876,484
Accumulated Other Comprehensive Gain	140,670	21,393
Accumulated Deficit	(3,780,106)	(2,039,596)
Total Stockholders' Deficit	(1,579,286)	(117,772)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 5,455,256	$ 5,994,579

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2015	Dec. 31, 2014
Statement of Financial Position [Abstract]
Preferred stock, par value in dollars	$ 0.001	$ 0.001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value in dollars	$ 0.001	$ 0.001
Common stock, shares authorized	500,000,000	500,000,000
Common stock, shares issued	25,391,481	23,946,481
Common stock, shares outstanding	25,391,481	23,946,481

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Revenue:
Sales	$ 7,103,036	$ 5,445,206
Less: Cost of Sales	3,742,106	3,156,031
Gross Margin	3,360,930	2,289,175
Operating Expenses:
Labor	1,297,761	722,725
General and Administrative	746,222	335,474
Rent Office Space and Servers	551,268	228,895
Depreciation	546,338	231,955
Legal and Professional	390,300	248,350
Bad Debt Expense:
Increase in allowance for Doubtful Accounts - Third Party Billings (Florida Operations)	275,000	0
Increase in allowance for Doubtful Accounts - Direct Billings	15,209	47,555
Total Bad Debt Expense	290,209	47,555
Insurance	92,055	49,469
Travel	41,067	42,378
Advertising	37,005	58,727
Management Fees	33,613	25,966
Amortization	0	22,924
Total Operating Expenses	4,025,838	2,014,418
Income from Operations	(664,908)	274,757
Other Income and (Expenses):
Other Income	68,174	1,710
Debt Settlement Loss	0	3,745
Foreign Currency Gains (Losses)	(34,826)	880
Interest & Penalties Expense	(495,829)	(339,695)
Amortization of Debt Discount	(613,121)	(116,904)
Total Other Income (Expenses)	(1,075,602)	(450,264)
Loss Before Provision for Income Taxes	(1,740,510)	(175,507)
Provision for Income (Taxes) Credit	0	5,385
Net Loss	(1,740,510)	(170,122)
Comprehensive Income (Loss)	119,277	14,685
Total Comprehensive Income (Loss)	$ (1,621,233)	$ (155,437)
Basic and Diluted Loss per Share	$ (0.067)	$ (0.007)
Weighted Average Shares Outstanding - Basic and Diluted	24,159,122	23,749,180

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholder's Deficit - USD ($)	Common Stock	Additional Paid-In Capital	Other Comprehensive Loss	Accumulated Deficit	Total
Beginning Balance at Dec. 31, 2013	$ 23,422	$ 1,837,079	$ 6,708	$ (1,869,474)	$ (2,265)
Beginning Balance - shares at Dec. 31, 2013	23,421,481
Shares issued for Services. value	$ 150	145			150
Shares issued for Services - shares	5,000
Shares Issued for Convertible Notes, value	$ 520	39,260			39,780
Shares Issued for Convertible Notes - shares	520,000
Comprehensive income (Loss)			14,685		14,685
Net Loss				(170,122)	(170,122)
Ending Balance at Dec. 31, 2014	$ 23,947	1,876,484	21,393	(2,039,596)	(117,772)
Ending Balance - shares at Dec. 31, 2014	23,946,481
Shares issued for Services. value	$ 1,425	64,040			65,465
Shares issued for Services - shares	1,425,000
Shares Issued for Convertible Notes, value	$ 20	1,020			1,040
Shares Issued for Convertible Notes - shares	20,000
Comprehensive income (Loss)			119,277		119,277
Options issued		82,579			82,579
Warrants Issued		10,635			10,635
Net Loss				(1,740,510)	(1,740,510)
Ending Balance at Dec. 31, 2015	$ 25,392	$ 2,034,758	$ 140,670	$ (3,780,106)	$ (1,579,286)
Ending Balance - shares at Dec. 31, 2015	25,391,481

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Income (Loss)	$ (1,740,510)	$ (170,122)
Adjustments to Reconcile Net Loss to Net Cash provided by Operating Activities:
Depreciation	546,338	231,955
Asset Write Off	0	928
Accrued Interest Converted into note	0	0
Amortization of Debt Discount	613,121	89,881
Stock-Based Compensation	148,044	150
Amortization of Intangible Assets	0	22,924
Foreign Currency Transaction (Gain) Loss	(2,130)	783
Change in allowance for Doubtful Accounts - Direct Billings	(8,198)	47,378
Change in allowance for Doubtful Accounts - Third Party Billings (Florida Operations)	275,000	0
Changes in operating assets and liabilities:
Accounts Receivable	(295,128)	(603,648)
Prepaid Expenses	4,961	(18,801)
Loans Receivable	1,497	549
Accounts Payable and Accrued Liabilities	857,078	327,537
NET CASH AND CASH EQUIVALENTS PROVIDED BY (USED IN) OPERATING ACTIVITIES	400,073	(70,486)
CASH FLOWS FROM INVESTING ACTIVITIES:
Payments on acquisition liability	0	(110,063)
Investments in PIV	0	(959,286)
Investments in PIN	0	(533,571)
Investments in PIC	0	(307,143)
Deposit on Equipment	0	(294,469)
Equipment Purchase	(45,251)	0
NET CASH USED IN INVESTING ACTIVITIES	(45,251)	(2,204,532)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from Promissory Notes	1,327,679	50,000
Proceeds from Convertible Debt	20,000	495,000
Proceeds from Royalty Financing	0	2,000,000
Royalty Fee Payment	(410,189)	0
Principal Payment on Convertible Debt	(60,000)	(20,034)
Principal Payments on Promissory Notes	(1,234,549)	(40,000)
Principal Payments on Capital Lease Obligations	(195,332)	(113,727)
NET CASH AND CASH EQUIVALENTS USED BY IN FINANCING ACTIVITIES	(552,391)	2,371,239
Gain (Loss) due to foreign currency translation	119,277	14,685
NET CHANGE IN CASH AND CASH EQUIVALENTS	(78,292)	110,906
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	188,206	77,300
CASH AND CASH EQUIVALENTS AT END OF PERIOD	109,914	188,206
Cash paid during the year for:
Interest	483,061	339,695
Income Taxes	27,280	71,460
Non-cash financing and investing activities:
Shares Issued for Convertible Note	1,040	39,780
Warrants Issued for Converted Notes	10,635	0
Acquisition Liability Assigned to Loan Payable	0	64,937
Acquisition Liability Assigned to Promissory Note	0	25,000
Equipment purchase under capital lease	18,384	432,798
Accrued Interest converted to Note	$ 15,000	$ 286,719

Organization and Summary of Sig

Organization and Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Summary of Significant Accounting Policies	Note 1 Organization and Summary of Significant Accounting Policies Organization and Basis of Presentation Basis of Presentation These consolidated financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States, and are expressed in U.S. dollars. The Company’s fiscal year-end is December 31. Principle of Consolidation The consolidated financial statements include the accounts of Medical Imaging, Corp., and its wholly-owned subsidiaries, CTS, SMI, PIV, PIN, and PIC. Intercompany accounts and transactions have been eliminated in the consolidated financial statements. CTS’, SMI’s, PIV’s, PIN’s, and PIC’s accumulated earnings prior to their acquisitions are not included in the consolidated balance sheet. Reclassification of Accounts Certain prior period amounts have been reclassified to conform to December 31, 2015 presentation. Use of Estimates and Assumptions The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States (“GAAP”) requires management to make estimates and assumptions that affect (i) the reported amounts of assets and liabilities, (ii) the disclosure of contingent assets and liabilities known to exist as of the date the consolidated financial statements are published, and (iii) the reported amount of net sales, expenses and costs recognized during the periods presented. Adjustments made with respect to the use of estimates often relate to improved information not previously available. Uncertainties with respect to such estimates and assumptions are inherent in the preparation of consolidated financial statements; accordingly, actual results could differ from these estimates. Cash and Cash Equivalents The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. At December 31, 2015, and 2014, cash includes cash on hand and cash in the bank. Accounts Receivable Credit Risk The allowance for doubtful accounts is maintained at a level sufficient to provide for estimated credit losses based on evaluating known and inherent risks in the receivables portfolio. Management evaluates various factors including expected losses and economic conditions to predict the estimated realization on outstanding receivables. As of December 31, 2015 and 2014, the allowance for doubtful accounts from direct billings was $56,475 and $64,673, respectively. Increase in allowance for doubtful accounts from direct billings for the years ended December 31, 2015 and 2014 was $15,209 and $47,555, respectively. As of December 31, 2015 and 2014, the allowance for doubtful accounts from third party billings (Florida operations) was $275,000 and $0, respectively. Increase in allowance for doubtful accounts from third party billings (Florida operations) for the years ended December 31, 2015 and 2014 was $275,000 and $0, respectively. In connection with the acquisition of the three facilities located in Venice, Port Charlotte and Naples, Florida, the Company, in October 2014, entered into professional services agreements whereby the seller of those three facilities continued to handle the billing and collection for the imaging centers (the “third party billing”). The seller must still provide a full set of verification data to the Company with respect to its account receivable processing and collections so that the Company can determine the extent to which accounts submitted by the seller in connection with the third party billing have been collected or denied. Final verification will only be able to be completed after the conclusion of the services performed pursuant to the third party billing contract, which is expected during the 2016 fiscal year. Goodwill and Indefinite Intangible Assets The Company follows the provisions of Financial Accounting Standard (“FASB”) Accounting Standards Codification (“ASC”) Topic 350, Goodwill and Other Intangible Assets No Goodwill impairment was recognized during 2015 or 2014. Revenue Recognition The Company holds contracts with several hospitals and groups of health care facilities to provide Teleradiology services for a specific period of time. The Company bills for services rendered on a monthly basis. For the year ended December 31, 2015, CTS held six contracts; four contracts that are renewable on a year-to-year basis and two contracts that are renewable in 2016 and 2018. In accordance with the requirement of Staff Accounting Bulletin (“SAB”) 104, the Company recognizes revenue when: (1) persuasive evidence of an arrangement exists (contracts); (2) delivery has occurred (monthly); (3) the seller’s price is fixed or determinable (per the customer’s contract, and services performed); and (4) collectability is reasonably assured (based upon our credit policy). Revenue is accounted for under the guidelines established by SAB 101, Revenue Recognition in Financial Statements, Revenue Recognition – Principal Agent Considerations For SMI, PIV, PIN, and PIC, revenue is recognized on the date of service and recorded on an aggregate monthly basis. Cost of Sales Cost of sales includes fees paid to radiologists for reading services, transcription fees, equipment repairs, system license and usage costs. Impairment of Long-Lived Assets In accordance with ASC Topic 360, Property, Plant and Equipment, Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset. Amortization and Depreciation Depreciation and amortization are calculated using the straight-line method over the following useful lives: 3 - 7 years Equipment 5 – 7 years Furniture and Fixtures 2 to 5 years Hospital Contracts 3 - 5 years Non-compete Contract 5 - 39 years Leasehold Improvements Stock based compensation The Company follows ASC 718, Stock Compensation The Company measures all share-based payments to employees (which includes non-employee Board of Directors), including employee stock options, warrants and restricted stock, at the fair value of the award and expenses it over the requisite service period (generally the vesting period). The fair value of common stock options or warrants granted to employees is estimated at the date of grant using the binomial option pricing model (“BOPM”). The calculation also takes into account the common stock fair market value at the grant date, the exercise price, the expected life of the common stock option or warrant, the dividend yield and the risk-free interest rate. The Company from time to time may issue stock options, warrants and restricted stock to acquire goods or services from third parties. Restricted stock, options or warrants issued to other than employees or directors are recorded on the basis of their fair value. The options or warrants are valued using the BOPM on the basis of the market price of the underlying equity instrument on the “valuation date,” which for options and warrants related to contracts that have substantial disincentives to non-performance, is the date of the contract, and for all other contracts is the vesting date. Expenses related to the options and warrants are recognized on a straight-line basis over the period which services are to be received. For the year ended December 31, 2015, the Company recognized stock-based compensation expenses from stock granted to non-employees of $34,683 from stock options and $20,250 from stock issued. The options were valued using the BOPM and included in the legal and professional operating expenses in the consolidated statements of operations. There was no stock-based compensation expense to non-employees for the year ended December 31, 2014. For the year ended December 31, 2015, the Company recognized stock-based compensation expenses of $47,896 from stock options, and $45,215 from stock granted to employees. The options were valued using the BOPM and included in the labor and management fees operating expenses in the consolidated statements of operations for $34,683, and $13,213, respectively. For the year ended December 31, 2014, the Company recognized stock granted to employees of $150. Fair Value of Financial Instruments The fair value of a financial instrument is the amount at which the instrument could be exchanged in a current transaction between willing parties other than in a forced sale or liquidation. The carrying amounts of the Company’s financial instruments, including cash, accounts receivable, prepaid expenses, accounts payable, accrued liabilities and notes and loans payable approximate fair value due to their most maturities. Fair Value Measurements The Company follows paragraph 825-10-50-10 of the FASB AS for disclosures about fair value of its financial instruments and paragraph 820-10-35-37 of the FASB ASC (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in U.S. GAAP, and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below: Level 1 Quoted market prices available in active markets for identical assets or liabilities as of the reporting date. Level 2 pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. Level 3 pricing inputs that are generally observable inputs and not corroborated by market data. The carrying amounts of the Company’s financial assets and liabilities, such as cash and accounts payable approximate their fair values because of the short maturity of these instruments. The Company does not have assets and liabilities that are carried at fair value on a recurring basis. Foreign Currency Translation The Company’s functional currency for its wholly-owned subsidiary, CTS, is the Canadian dollar, and their financial statements have been translated into U.S. dollars. The Canadian dollar based accounts of the Company’s foreign operations have been translated into United States dollars using the current rate method. Assets and liabilities of those operations are translated into U.S. dollars using exchange rates as of the balance sheet date; income and expenses are translated using the weighted average exchange rates for the reporting period. Translation adjustments are recorded as accumulated other comprehensive income (loss), a separate component of stockholders’ equity. The Company recognized a foreign currency loss on transactions from operations of $34,826 and foreign currency gain of $880 for the years ended December 31, 2015 and 2014, respectively. The Company recognized other comprehensive gain of $119,277 and $14,685 for the years ended December 31, 2015 and 2014, respectively. Income Taxes The Company accounts for income taxes in accordance with ASC Topic 740, Income Taxes Net Income (Loss) Per Share The Company follows the provisions of ASC Topic 260, Earnings per Share Basic earnings per share is computed by dividing net income available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted earnings per share reflects the potential dilution that could occur if stock options and other commitments to issue common stock were exercised or equity awards vest resulting in the issuance of common stock or conversion of notes into shares of the Company’s common stock that could increase the number of shares outstanding and lower the earnings per share of the Company’s common stock. This calculation is not done for periods in a loss position as this would be antidilutive. The information related to basic and diluted earnings per share is as follows: Years Ended December 31, 2015 December 31, 2014 Total Comprehensive Loss $ (1,621,233) $ (155,437) Denominator: Weighted average number of shares outstanding – basic and diluted 24,159,122 23,749,180 EPS: Basic and Diluted $ (0.067) $ (0.007) Recent Accounting Updates The Company does not expect the adoption of any other recently issued accounting pronouncements to have a significant impact on its results of operations, financial position or cash flow. Updates issued but not yet adopted The Company does not expect the adoption of any other recently issued accounting pronouncements to have a significant impact on its results of operations, financial position or cash flow.

Property and Equipment

Property and Equipment	12 Months Ended
	Dec. 31, 2015
Property, Plant and Equipment [Abstract]
Property and Equipment	Note 2. Property and Equipment Property and equipment are stated at cost. Depreciation is calculated using the straight - line method over the estimated useful life of the assets. At December 31, 2015 and 2014, the major class of property and equipment were as follows: December 31, 2015 December 31, 2014 Estimated useful lives Computer/Office Equipment $ 454,117 $ 435,867 3-7 years Medical Equipment 2,156,820 2,123,023 3-7 years Leasehold Improvements 843,781 843,781 5- 39 years Less: Accumulated Depreciation (998,224) (463,977) Net Book Value $ 2,456,494 $ 2,938,694 Depreciation expense was $546,338 and $231,955 for the year ended December 31, 2015 and, 2014, respectively.

Business Combination

Business Combination	12 Months Ended
	Dec. 31, 2015
Business Combinations [Abstract]
Business Combination	Note 3. Business Combination On October 31, 2014, the Company acquired 100% of the equity interests of three separate entities, Partners Imaging Center of Venice, LLC (PIV), Partners Imaging Center of Naples, LLC (PIN) and Partners Imaging Center of Charlotte, LLC (PIC) for an aggregate cash consideration described in detail below. Each company was purchased for its medical equipment, general office fixtures, Medicare number and facility lease. There were no prior earnings, accounts receivable, accounts payable, or other assets or liabilities acquired in any of the acquisitions. Medical imaging services began to be offered on October 31, 2014 by PIV, PIN, and PIC. The Company paid an aggregate purchase price of $1,800,000 as follows (at fair value): Total PIV PIN PIC Cash $ 1,800,000 959,286 533,571 307,143 Total consideration paid $ 1,800,000 959,286 533,571 307,143 The following assets and liabilities were recognized (at fair value): Total PIV PIN PIC Fixed Assets $ 1,245,000 695,000 375,000 175,000 Goodwill 555,000 264,286 158,571 132,143 Net assets purchased $ 1,800,000 959,286 533,571 307,143 The Company has evaluated the transactions and believes that the historical cost of the tangible and intangible assets acquired approximated the fair market value given the current nature of the assets acquired. As part of the acquisitions the Company has acquired aggregate Goodwill of $555,000. The Company expects to amortize the full amounts of goodwill for tax purposes. The Company will perform annual testing of goodwill for impairment. The amounts of revenue and gross earnings included in the consolidated income statement for the years ended December 31, 2015 and 2014 are as follow: Year Ended December 31, 2015 Total PIV PIN PIC Revenue $ 5,035,074 1,325,993 727,237 830,983 Gross Earnings $ 1,666,746 726,596 436,112 504,038 Year Ended December 31, 2014* Total PIV PIN PIC Revenue $ 518,449 239,037 128,015 151,397 Gross Earnings $ 387,064 174,311 96,679 116,074 *For the year ended December 31, 2014, amounts included for PIV, PIN, and PIC’s revenue and gross earnings, represent two months of operations post the October 31, 2014 acquisitions date. Costs related to the acquisitions, which include legal fees, in the aggregate amount of about $29,500, have been charged directly to operations and are included in legal and professional expenses in the 2014 consolidated income statement.

Goodwill

Goodwill	12 Months Ended
	Dec. 31, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	Note 4. Goodwill Balance as of January 1, 2014 $ 1,422,670 Acquisition of goodwill during the year 555,000 Changes in goodwill during the year - Balance as of December 31, 2014 1,977,670 Changes in goodwill during the year - Balance as of December 31, 2015 $ 1,977,670

Operating Lease Commitments

Operating Lease Commitments	12 Months Ended
	Dec. 31, 2015
Leases, Operating [Abstract]
Operating Lease Commitments	Note 5. Operating Lease Commitments CTS has a lease commitment for its office space of approximately $2,450 minimum rental, and approximately $3,550 in utilities, realty taxes, and operating costs, for a total of approximately $6,000 per month. The lease renewed in April 2013 for a period of five years and will expire in March 2018. On renewal, CTS was given a rental credit of approximately $28,000. SMI entered into a lease commitment for its office space in Pottsville, Pennsylvania. The lease will expire on June 30, 2016, and it is renewable for an additional term of 5 years on the same terms and conditions. Monthly rental amounts are $5,437 per month plus approximately $1,674 in utilities, realty taxes, and operating costs. SMI has a lease for its x-ray equipment space in Pottsville, Pennsylvania. The lease term is seven years from commitment date of October 2014. Monthly lease payments are $2,000. SMI has a lease for office space in Dallas, Texas of approximately $880 per month. The lease will expire in August 31, 2016. PIV has a lease for office space in Venice, Florida. The lease will expire October 1, 2016. Monthly rental amounts are $15,377 per month. PIN has a lease for office space in Naples, Florida. The lease will expire January 1, 2020. Monthly rental amounts are $9,543 per month. PIC has a lease for office space in Port Charlotte, Florida. The lease will expire June 20, 2016. Monthly rental amounts are $5,512 per month. Expected lease commitments as of December 31, 2015: Year Total 2016 $ 379,043 2017 167,916 2018 145,866 2019 138,516 2020 138,516 Thereafter 18,000 $ 987,857

Obligations Under Capital Lease

Obligations Under Capital Lease	12 Months Ended
	Dec. 31, 2015
Leases, Capital [Abstract]
Obligations Under Capital Lease	Note 6. Obligations Under Capital Lease SMI MRI Machines Capital Lease: On December 10, 2012, the Company entered into a lease agreement with one of the sellers of SMI to lease the two MRI machines. Under the terms of the lease, SMI is to make monthly payments of $11,013, plus applicable sales tax, over a period of 48 months. In addition, SMI agreed to make a one-time lease payment of $125,000, which was paid by March 30, 2013. The Company has guaranteed all of SMI’s obligations under the lease. At the end of the lease, SMI will have the option to purchase the MRI machines for a total purchase price of $1.00. The lease was accounted for as a capital lease for a total value of $555,000. The gross amount of the equipment held under capital leases totals $555,000. Net book value at December 31, 2015 was $218,833 after accumulated depreciation of $342,167. Net book value at December 31, 2014 was $323,833 after accumulated amortization of $231,167, at December 31, 2014. Amortization of the capital lease assets is included in the depreciation expense of $111,000 for the years ended December 31, 2015, and 2014. SMI X-ray Machine Capital Lease: On July 3, 2014, Company entered into a capital lease agreement to lease the x-ray machine that was delivered and installed in July 2014. Under the terms of the lease, the Company’s subsidiary, SMI, is to make monthly payments of $1,495, plus applicable sales tax, over a period of 60 months. At the end of the lease, SMI will have the option to purchase the MRI machines for a total purchase price of $1.00. The lease was accounted for as a capital lease for a total value of $78,250. The gross amount of the x-ray machine held under the capital lease is $78,250. Net book value at December 31, 2015 was $54,775 after accumulated amortization of $23,475. Net book value at December 31, 2014 was $70,425 after accumulated amortization of $7,825. Amortization of the capital lease assets is included in the depreciation expense of $15,650, and $7,825 for the years ended December 31, 2015, and 2014, respectively. SMI PACS/RIS System Capital Lease: On August 19, 2014, the Company entered into a capital lease agreement to lease PACS/RIS system that was delivered and installed in December 2014. Under the terms of the lease, the Company’s subsidiary, SMI, is to make monthly payments of $3,115, plus applicable sales tax, over a period of 60 months. At the end of the lease, SMI will have the option to purchase the system for a total purchase price of $1.00. The lease was accounted for as a capital lease for a total value of $162,333. The gross amount of the PACS/RIS system held under the capital lease is $162,333. Net book value at December 31, 2015 was $124,455 after accumulated amortization of $37,878. Net book value at December 31, 2014 was $156,922 after accumulated amortization of $5,411 Amortization of the capital lease assets is included in the depreciation expense of $32,467, and $5,411 for the years ended December 31, 2015, and 2014, respectively. PV, PN, PC PACS/RIS Capital Lease: On November 26, 2014, the Company entered into a capital lease agreement to lease PACS/RIS system that was delivered and installed in December 2014. Under the terms of the lease, the Company’s subsidiary, PIV, is to make monthly payments of $3,094, plus applicable sales tax, over a period of 60 months. At the end of the lease, PIV will have the option to purchase the system for a total purchase price of $1.00. The lease was accounted for as a capital lease for a total value of $167,107. The gross amount of the PACS/RIS system held under the capital lease is $167,107. Net book value at December 31, 2015 was $132,292 after accumulated amortization of $34,815. Net book value at December 31, 2014 was $165,714 after accumulated amortization of $1,393. Amortization of the capital lease assets is included in the depreciation expense of $33,422, and $1,393 for the years ended December 31, 2015, and 2014, respectively. PV, PN, PC Computers Capital Lease: On December 10, 2014, the Company entered into a capital lease agreement to lease computers that were delivered and installed in December 2014. Under the terms of the lease, the Company is to make monthly payments of $813, plus applicable sales tax, over a period of 36 months. At the end of the lease, the company will have the option to purchase the computers for a total purchase price of $1.00. The lease was accounted for as a capital lease for a total value of $25,108. The gross amount of the computers held under the capital lease is $25,108. Net book value at December 31, 2015 was $16,390 after accumulated amortization of $8,718. Net book value at December 31, 2014 was $24,759 after accumulated amortization of $349. Amortization of the capital lease assets is included in the depreciation expense of $8,369, and $349 for the years ended December 31, 2015, and 2014, respectively. CTS Computers Lease On January 21, 2015, the Company entered into a capital lease agreement to lease computers that were installed on the same date of acceptance. Under the terms of the lease, the Company is to make monthly payments of $529, plus applicable sales tax, over a period of 36 months. At the end of the lease, the Company will have the option to purchase the computers for a total purchase price of $1.00. The lease was accounted for as a capital lease for a total value of $18,384. The gross amount of the computers held under the capital lease is $18,997. Net book value at December 31, 2015 was $12,767 after accumulated amortization of $6,230. Amortization of the capital lease assets is included in the depreciation expense of $5,617, and $0 for the years ended December 31, 2015, and 2014, respectively. Minimum future lease payments under the capital leases as of December 31, 2015 are as follow: Minimum Lease Payments Total 2016 $ 228,597 2017 107,740 2018 93,509 2019 83,356 2020 3,094 Total minimum lease payments 516,297 Less amount representing interest 43,411 Present value of minimum lease payments 472,886 Less current portion of minimum lease payments 205,740 Long-term capital lease obligations at December 31, 2015 $ 267,146

Promissory Notes

Promissory Notes	12 Months Ended
	Dec. 31, 2015
Debt Disclosure [Abstract]
Promissory Notes	Note 7. Promissory Notes In December 2014, the Company issued a short term loan payable to a non-related party for $50,000 in proceeds. The note was due on demand and did not accrue interest. For the year ended December 31, 2015, the Company received additional proceeds of $4,000 and made payments of $54,000 towards the balance and the loan was paid in full. For the year ended December 31, 2015, the Company issued loans totaling $720,000. The loans’ terms call for total weekly payments of $28,000 towards the principal balance and interest. The loans were collateralized by the Accounts Receivable of PIV, PIN, and PIC. The final payment was due August 18, 2015. The loans were paid in full by the maturity date. For the year ended December 31, 2015, the Company issued loans totaling $559,000. The loans call for weekly payments of $13,000 towards the principal balance and interest. The loans were collateralized by the Accounts Receivable of PIV, PIN, and PIC. The notes were paid off early on February 29, 2016. The early pay off resulted in a saving of $20,000 in interest. In June and December 2015, the Company has issued loans of $120,700 and $86,400, respectively. The loans’ terms call for a daily payment of $509, towards the principal balance and interest. The final payment is due February 14, 2017. The loans are collateralized by the Accounts Receivable of: SMI, PIV, PIN, and PIC. In June 2015, the Company issued a loan of $147,224. The loan terms call for a daily payment of $553, towards the principal balance and interest. The loans were collateralized by the Accounts Receivable of: CTS SMI, PIV, PIN, and PIC. The final payment had an original maturity date of July 7, 2016. The note was paid off early on March 2, 2016. A summary of the promissory notes is as follows: Issuance Date December 31, 2014 Balance Notes Issued Payments Unamortized Discount December 31, 2015 Balance Maturity Date 21-Mar-11 $ 20,062 $ - (12,310) $ - $ 7,752 18-Mar-16 01-Jun-14 64,937 - (64,937) - - 18-Feb-15 23-Dec-14 50,000 4,000 $ (54,000) - - On Demand 16-Jun-15 - 207,100 (61,402) (37,242) 108,456 14-Feb-17 16-Jun-15 - 147,224 (74,858) (13,785) 58,581 07-Jul-16 17-Feb-15 - 216,000 (216,000) - - 13-Apr-15 13-Mar-15 - 168,000 (168,000) - - 26-May-15 17-Apr-15 - 168,000 (168,000) - - 06-Jul-15 27-May-15 - 168,000 (168,000) - - 18-Aug-15 04-Aug-15 - 260,000 (247,000) (3,000) 10,000 05-Jan-16 22-Sep-15 - 169,000 - (44,000) 125,000 29-Feb-16 22-Dec-15 - 130,000 - (30,000) 100,000 29-Feb-16 Total $ 134,999 $ 1,637,324 $ (1,234,507) $ (128,027) $ 409,789

Convertible Notes

Convertible Notes	12 Months Ended
	Dec. 31, 2015
Debt Disclosure [Abstract]
Convertible Notes	Note 8. Convertible Notes Series B: On December 5, 2012 and March 27, 2013, the Company sold, through a private placement to accredited investors, three year 12% convertible notes (“Series B Notes”) in the aggregate principal amount of $1,865,000, and $365,000, respectively. The Notes pay interest at a rate of 12% per annum, payable to the holder at 1% per month, and are convertible into common shares of the Company at $0.15 per share. In addition, each purchaser of the Notes received shares dependent on the dollar amount of Notes purchased. The total number of shares of common stock issued was 5,315,000 shares. In accordance with ASC 470, Debt with conversion and other options, (“ASC 470”) On December 1, 2015, the holders of $1,840,000 Series B Notes have agreed to extend the maturity date of the debt outstanding to July 1, 2017 from its original maturity date of December 31, 2015. As part of the extension the Company issued warrants to entitle the holders to purchase up to 1,840,000 shares of common stock at an exercise price of $0.07 per share at any time from December 1, 2015 to July 1, 2018. In accordance with ASC 480, Distinguishing Liabilities from Equity, • The debt can be transferred without the transfer of the warrants. • The warrants can be transferred without the transfer of the debt. • The warrants can be exercised while debt still outstanding. In accordance with ASC 470, if the warrants are classified as equity, then the proceeds should be allocated based on the relative fair values of the base instrument and the warrants following the guidance as in ASC 470. The Company has valued the warrants at $0.0058 per issued share, and recorded a total discount of $10,672 to be amortized over the extension period on a monthly basis. This is from January 2016 to July 2017, an 18 month period. For the year ended December 31, 2015, $241,800 of accrued interest was recorded on the notes and $226,800 was paid. The Details of Series B Notes are as follows: December 31, 2014 Balance Unamortized Discount December 31, 2015 Balance Maturity Date 03-Dec-12 $ 25,000 $ (145) $ 24,856 01-Jul-17 03-Dec-12 125,000 (1,498) 123,502 01-Jul-17 03-Dec-12 50,000 (289) 49,711 01-Jul-17 03-Dec-12 25,000 (145) 24,856 01-Jul-17 03-Dec-12 25,000 (145) 24,856 01-Jul-17 03-Dec-12 25,000 (145) 24,856 01-Jul-17 03-Dec-12 1,500,000 (8,670) 1,491,330 01-Jul-17 03-Dec-12 50,000 (289) 49,711 01-Jul-17 03-Dec-12 15,000 (87) 14,913 01-Jul-17 03-Dec-12 100,000 (387) 99,613 01-May-16 27-Mar-13 25,000 (129) 24,871 01-Sep-17 27-Mar-13 25,000 (129) 24,871 01-Sep-17 27-Mar-13 25,000 (129) 24,871 01-Sep-19 Total $ 2,015,000 $ (12,185) $ 2,002,815 Following are maturities of the long –term debt in Series B Notes for each of the next 5 years: Principal Payments 2016 $ 100,000 2017 1,890,000 2018 - 2019 25,000 Total $ 2,015,000 Series C: The Notes bear interest at a rate of 12% per annum, payable to the holder at1% per month, with the principal amount due on May 31, 2017. The Notes are convertible into shares of the Company’s common stock at an initial conversion rate of $0.15 per share. In addition, each holder of Series C Notes received shares dependent on the dollar amount of Notes purchased. On August 25, 2014, October 31, 2014 and February 17, 2015, the Company sold an additional $75,000, $50,000 and $20,000, respectively of Series C Notes. The total number of shares of common stock issued was 240,000 shares. In accordance with ASC 470 on issuance of the shares, the Company recognized additional paid-in capital and a discount against the notes for a total of $12,695. Amortization of the discount for the year ended December 31, 2015 was $5,049. For the year ended December 31, 2015, $28,400 in accrued interest was recorded on the notes and paid. Issuance Date Balance at December 31, 2014 Proceeds Unamortized Discount Balance at December 31, 2015 Balance at December 31, 2015 22-May-14 $ 50,000 $ - $ (1,417) $ 48,583 31-May-17 22-May-14 22,500 - (638) 21,863 31-May-17 22-May-14 22,500 - (638) 21,863 31-May-17 25-Aug-14 50,000 - (2,095) 47,905 31-Oct-17 25-Aug-14 25,000 - (1,048) 23,952 31-Oct-17 31-Oct-14 50,000 - (1,604) 48,396 31-Oct-17 17-Feb-15 - 20,000 (751) 19,249 17-Feb-18 Total $ 220,000 $ 20,000 $ (8,190) $ 231,810 Following are maturities of the long –term debt in Series C Notes: Principal Payments 2016 $ - 2017 220,000 2018 20,000 Total $ 240,000 Individually issued Convertible Note: On March 26, 2014, the Company issued a $300,000 convertible note to a non-affiliate. The note pays interest at a rate of 12% per annum, payable to the holder at 1% per month. In addition to interest payments the Company will be making monthly payments of $5,000 towards the principal balance beginning June 1, 2014 for three years until the note due date of February 27, 2017. The note is convertible into common shares of the Company at $0.15 per share. In addition, the Note holder will receive 300,000 shares as part of the note agreement. For the year ended December 31, 2015, $27,884 of interest was recorded on the notes and paid. In accordance with ASC 470 on issuance of the shares, the Company recognized additional paid-in capital and a discount against the notes for a total of $25,500. Amortization of the discount for the year ended December 31, 2015 was $8,500. Summary of the note is as follows: Issuance Date December 31, 2014 Balance Payments Unamortized Discount December 31, 2015 Balance Maturity Date 26-Mar-14 $ 300,000 $ (100,000) $ (10,625) $ 189,375 27-Feb-17 Following are maturity of the individually issued: Principal Payments 2016 $ 60,000 2017 140,000 Total $ 200,000

Royalty Financing

Royalty Financing	12 Months Ended
	Dec. 31, 2015
Royalty Financing
Royalty Financing	Note 9. Royalty Financing On October 31, 2014, the Company entered into a royalty purchase agreement with Grenville Strategic Royalty Corp. for the amount of $2,000,000. The agreement calls for a monthly payment to Grenville based on a percentage of the total of certain revenue items and subject to a minimum payment amount. As of December 31, 2015, the Company paid a total of $446,377 in royalty payments. The amount financed is recorded net of discount to be amortized during the term. For the years ended December 31, 2015 and 2014, the Company has recorded discount amortization expense of $340,372 and $40,948, respectively. The balance as shown on the consolidated balance sheet as of December 31, 2015 was $1,935,101, net of $5,618,680 in unamortized discount.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2015
Income Tax Disclosure [Abstract]
Income Taxes	Note 10. Income Taxes ASC 740 requires the recognition of deferred tax liabilities and assets for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns. Under this method, deferred tax liabilities and assets are determined based on the difference between consolidated financial statements and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. For the year ended December 31, 2015, the Company had a cumulative net operating loss carryover of approximately $1,621,233 available for U.S federal income tax, which expire beginning in 2017. The net operating loss carryovers may be subject to limitations under Internal Revenue Code due to significant changes in the Company’s ownership. The Company has provided a full valuation allowance against the full amount of the net operating loss benefit, since, in the opinion of management, based upon the earnings history of the Company, it is more likely than not that the benefits will not be realized. Deferred net tax asset (34%) consists of the following at December 31, 2015: 2015 2014 Deferred tax asset $ 1,062,352 $ 563,981 Less valuation allowance (1,062,352) (563,981) Net deferred tax asset $ - $ - A reconciliation between income taxes at statutory tax rates (34%) and the actual income tax provision for continuing operations as of December 31, 2015 follows: 2015 2014 Expected Provision (based on statutory rate) $ (551,219) $ (52,849) Increase to deferred tax valuation allowance for net operating loss carry forward 551,219 52,849 Net provision $ - $ - The Company has filed its tax returns through December 31, 2014, and filed for a six months extension on its December 31, 2015 tax return filing. The provisions of ASC 740 require companies to recognize in their financial statements the impact of a tax position if that position is more likely than not to be sustained upon audit, based upon the technical merits of the position. ASC 740 prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken on a tax return. ASC 740 also provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods and disclosure. Management does not believe that the Company has any material uncertain tax positions requiring recognition or measurement in accordance with the provisions of ASC 740. Accordingly, the adoption of these provisions of ASC 740 did not have a material effect on the Company’s financial statements. The Company’s policy is to record interest and penalties on uncertain tax positions, if any, as income tax expense. All past six tax years for the Company remain subject to future examinations by the applicable taxing authorities. As of December 31, 2015, CTS has incurred $16,480 in federal and provincial income taxes payable to Canada Revenue Agency, and recorded a provision for income taxes, accordingly. The Company has carried back loss incurred in 2014 and has received a credit of $43,311 in 2015. The Company has been making progress payments towards the balance owing. As of December 31, 2015 total payments made were $33,380.

Major Customers

Major Customers	12 Months Ended
	Dec. 31, 2015
Major Customers
Major Customers	Note 11. Major Customers In 2015 and 2014, revenue was derived primarily from medical imaging and radiology services. There were no major customers representing more than 10% of total revenue for the year ended December 31, 2015 or 2014. There were no closing balances for accounts receivable greater than 10% of total balance for the year ended December 31, 2015 or 2014.

Major Vendors and Service Agree

Major Vendors and Service Agreements	12 Months Ended
	Dec. 31, 2015
Major Vendors And Service Agreements
Major Vendors and Service Agreements	Note 12. Major Vendors and service agreements

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2015
Related Party Transactions [Abstract]
Related Party Transactions	Note 13. Related Party Transactions During January 2015, the Company entered into an agreement with a company that is owned and controlled by a major shareholder, to provide consulting services. Fees payable for performance of the consulting services are $10,000 per month. In addition to the monthly fees, the consultant was paid at signing of the agreement, four million two hundred thousand (4,200,000) options to purchase common stock of the client at an exercise price of $0.15 per share with an expiry date of December 31, 2019; details of the options recognition is disclosed in Note 15. On December 28, 2015, 450,000 shares of common stock were issued as compensation of $20,250 owed and outstanding towards the 2015 consulting agreement. Fees paid to the related party consultant are included as an expense in Legal and Professional fees in the accompanying statement of operations for the period. At December 31, 2015, the Company had $8,513 balance owing for services rendered.

Common Stock Transactions

Common Stock Transactions	12 Months Ended
	Dec. 31, 2015
Equity [Abstract]
Common Stock Transactions	Note 14. Common Stock Transactions For the year ended December 31, 2015, 1,425,000 shares were issued for services valued at $65,465 based upon the closing price of the Company’s common stock at the grant date. For the year ended December 31, 2015, 20,000 shares were issued as part of Series C convertible note agreements. The shares were valued at $1,040 based upon the closing price of the Company’s common stock at the grant date. On December 1, 2015, the Company issued 1,840,000 warrants to holders of Series B convertible notes (see Note 8) as part of the agreements to extend the maturity dates of the notes. The warrants are exercisable at a price of $0.07 per full share at any time from December 1, 2015 to July 1, 2018. The Company has valued the warrants at a $0.0058 per issued share. On January 27, 2015, the Company granted options as considerations for services provided by the CEO of the Company. The options are to purchase up to 4,200,000 shares of common stock, with an exercise price equal to $0.15 per share. The options shall have a five (5) year term. Inputs used in Binomial Option Pricing model were as follow: stock price at grant date: $0.0517, exercise price $0.15, expected life of the option two and a half (2.5) years, volatility of 70%, and risk free rate of 0.03%. The options were recorded on the grant date at a value of $34,683. On January 27, 2015, the Company granted options as considerations for consulting services provided to the Company. The options are to purchase up to 4,200,000 shares of common stock, with an exercise price equal to $0.15 per share. The options shall have a five (5) year term. Inputs used in Binomial Option Pricing model were as follow: stock price at grant date: $0.0517, exercise price $0.15, expected life of the option two and a half (2.5) years, volatility of 70%, and risk free rate of 0.03%. The options were recorded on the grant date at a value of $34,683. On January 27, 2015, the Company granted options as considerations for services provided by the CFO of the Company. The options are to purchase up to 1,600,000 shares of common stock, with an exercise price equal to $0.15 per share. The options shall have a five (5) year term. Inputs used in Binomial Option Pricing model were as follow: stock price at grant date: $0.0517, exercise price $0.15, expected life of the option two and a half (2.5) years, volatility of 70%, and risk free rate of 0.03%. The options were recorded on the grant date at a value of $13,213. For the year ended December 31, 2014, 5,000 shares were issued for services valued at $150 based upon the closing price of the Company’s common stock at the grant date. For the year ended December 31, 2014, 300,000 shares were issued as part of individually issued convertible note agreements. The shares were valued at $25,500 based upon the closing price of the Company’s common stock at the grant date. For the year ended December 31, 2014, 220,000 shares were issued as part of Series C convertible note agreements. The shares were valued at $14,280 based upon the closing price of the Company’s common stock at the grant date.

Going Concern

Going Concern	12 Months Ended
	Dec. 31, 2015
Going Concern
Going Concern	Note 15. Going Concern As shown in the accompanying consolidated financial statements, the Company incurred net loss of $1,621,233 for the year ended December 31, 2015 as well as a working capital deficit of $1,646,533. These conditions raise substantial doubt as to the Company’s ability to continue as a going concern. Management plans to raise additional financing in order to continue its operations and fulfill its debt obligations in 2016, but there can be no assurances that the plan will be successful. These consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2015
Subsequent Events [Abstract]
Subsequent Events	Note 16. Subsequent Events On February 23, 2016 the Company sold a bridge convertible promissory note for $100,000 to a private investor. The Note pays interest monthly at an annual rate of 12%. As an inducement to purchase the Note, the investor was also given 100,000 shares of common stock of the Company. The note is due on February 23, 2017 but may be converted into a future financing of notes sold by the Company. On February 25, 2016, the Company sold to Grenville Strategic Royalty Corp. (“Holder”) a convertible note for the principal amount of $500,000. The Note pays interest monthly at an annual rate of 25%.From July 30, 2016 through to August 31, 2017, the Holder may elect to convert the Note into a temporary royalty and receive a monthly payment equal to a specified percentage of the Company’s revenue for the previous month, subject to certain minimum payments, in lieu of interest payments. However, in such case the Company may still buy back the temporary royalty for the original face value of the Note. If the Note is outstanding as of August 31, 2017, then the Note may be converted into a permanent royalty based on the revenues of the Company (the “Royalty”) at the Holder's election, subject to certain minimum payments. The Holder will maintain a security interest in the Company until such time as the Note is retired, the Company raises $1,200,000 in additional capital, or the Note is converted into the Royalty. On February 29, 2016, promissory notes with a balance owing of $235,000 as of December 31, 2015, were paid off in full. As a result the company saved $20,000 in interest. On March 2, 2016, promissory notes with balance owing of $58,581 as of December 31, 2015, were paid off in full. On March 22, 2016, the Company sold additional $70,000 in a bridge convertible promissory note to a private investor. The Note pays interest monthly at an annual rate of 12%. As an inducement to purchase the Note, the investor was also given 70,000 shares of common stock of the Company. The note is due on March 22, 2017 but may be converted into a future financing of notes sold by the Company. The Company evaluated subsequent events through the date the consolidated financial statements were issued.

Accounting Policies (Policies)

Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2015
Accounting Policies [Abstract]
Organization and Basis of Presentation	Organization and Basis of Presentation Basis of Presentation These consolidated financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States, and are expressed in U.S. dollars. The Company’s fiscal year-end is December 31.
Principle of Consolidation	Principle of Consolidation The consolidated financial statements include the accounts of Medical Imaging, Corp., and its wholly-owned subsidiaries, CTS, SMI, PIV, PIN, and PIC. Intercompany accounts and transactions have been eliminated in the consolidated financial statements. CTS’, SMI’s, PIV’s, PIN’s, and PIC’s accumulated earnings prior to their acquisitions are not included in the consolidated balance sheet.
Reclassification of Accounts	Reclassification of Accounts Certain prior period amounts have been reclassified to conform to December 31, 2015 presentation.
Use of Estimates and Assumptions	Use of Estimates and Assumptions The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States (“GAAP”) requires management to make estimates and assumptions that affect (i) the reported amounts of assets and liabilities, (ii) the disclosure of contingent assets and liabilities known to exist as of the date the consolidated financial statements are published, and (iii) the reported amount of net sales, expenses and costs recognized during the periods presented. Adjustments made with respect to the use of estimates often relate to improved information not previously available. Uncertainties with respect to such estimates and assumptions are inherent in the preparation of consolidated financial statements; accordingly, actual results could differ from these estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. At December 31, 2015, and 2014, cash includes cash on hand and cash in the bank.
Accounts Receivable Credit Risk	Accounts Receivable Credit Risk The allowance for doubtful accounts is maintained at a level sufficient to provide for estimated credit losses based on evaluating known and inherent risks in the receivables portfolio. Management evaluates various factors including expected losses and economic conditions to predict the estimated realization on outstanding receivables. In connection with the acquisition of the three facilities located in Venice, Port Charlotte and Naples, Florida, the Company, in October 2014, entered into professional services agreements whereby the seller of those three facilities continued to handle the billing and collection for the imaging centers (the “third party billing”). The seller must still provide a full set of verification data to the Company with respect to its account receivable processing and collections so that the Company can determine the extent to which accounts submitted by the seller in connection with the third party billing have been collected or denied. Final verification will only be able to be completed after the conclusion of the services performed pursuant to the third party billing contract, which is expected during the 2016 fiscal year.
Goodwill and Indefinite Intangible Assets	Goodwill and Indefinite Intangible Assets The Company follows the provisions of Financial Accounting Standard (“FASB”) Accounting Standards Codification (“ASC”) Topic 350, Goodwill and Other Intangible Assets
Revenue Recognition	Revenue Recognition The Company holds contracts with several hospitals and groups of health care facilities to provide Teleradiology services for a specific period of time. The Company bills for services rendered on a monthly basis. For the year ended December 31, 2015, CTS held six contracts; four contracts that are renewable on a year-to-year basis and two contracts that are renewable in 2016 and 2018. In accordance with the requirement of Staff Accounting Bulletin (“SAB”) 104, the Company recognizes revenue when: (1) persuasive evidence of an arrangement exists (contracts); (2) delivery has occurred (monthly); (3) the seller’s price is fixed or determinable (per the customer’s contract, and services performed); and (4) collectability is reasonably assured (based upon our credit policy). Revenue is accounted for under the guidelines established by SAB 101, Revenue Recognition in Financial Statements, Revenue Recognition – Principal Agent Considerations For SMI, PIV, PIN, and PIC, revenue is recognized on the date of service and recorded on an aggregate monthly basis.
Cost of Sales	Cost of Sales Cost of sales includes fees paid to radiologists for reading services, transcription fees, equipment repairs, system license and usage costs.
Impairment of Long-Lived Assets	Impairment of Long-Lived Assets In accordance with ASC Topic 360, Property, Plant and Equipment, Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset.
Amortization and Depreciation	Amortization and Depreciation Depreciation and amortization are calculated using the straight-line method over the useful lives.
Stock Based Compensation	Stock based compensation The Company follows ASC 718, Stock Compensation The Company measures all share-based payments to employees (which includes non-employee Board of Directors), including employee stock options, warrants and restricted stock, at the fair value of the award and expenses it over the requisite service period (generally the vesting period). The fair value of common stock options or warrants granted to employees is estimated at the date of grant using the binomial option pricing model (“BOPM”). The calculation also takes into account the common stock fair market value at the grant date, the exercise price, the expected life of the common stock option or warrant, the dividend yield and the risk-free interest rate. The Company from time to time may issue stock options, warrants and restricted stock to acquire goods or services from third parties. Restricted stock, options or warrants issued to other than employees or directors are recorded on the basis of their fair value. The options or warrants are valued using the BOPM on the basis of the market price of the underlying equity instrument on the “valuation date,” which for options and warrants related to contracts that have substantial disincentives to non-performance, is the date of the contract, and for all other contracts is the vesting date. Expenses related to the options and warrants are recognized on a straight-line basis over the period which services are to be received.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of a financial instrument is the amount at which the instrument could be exchanged in a current transaction between willing parties other than in a forced sale or liquidation. The carrying amounts of the Company’s financial instruments, including cash, accounts receivable, prepaid expenses, accounts payable, accrued liabilities and notes and loans payable approximate fair value due to their most maturities.
Fair Value Measurements	Fair Value Measurements The Company follows paragraph 825-10-50-10 of the FASB AS for disclosures about fair value of its financial instruments and paragraph 820-10-35-37 of the FASB ASC (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in U.S. GAAP, and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below: Level 1 Quoted market prices available in active markets for identical assets or liabilities as of the reporting date. Level 2 pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. Level 3 pricing inputs that are generally observable inputs and not corroborated by market data. The carrying amounts of the Company’s financial assets and liabilities, such as cash and accounts payable approximate their fair values because of the short maturity of these instruments. The Company does not have assets and liabilities that are carried at fair value on a recurring basis.
Foreign Currency Translation	Foreign Currency Translation The Company’s functional currency for its wholly-owned subsidiary, CTS, is the Canadian dollar, and their financial statements have been translated into U.S. dollars. The Canadian dollar based accounts of the Company’s foreign operations have been translated into United States dollars using the current rate method. Assets and liabilities of those operations are translated into U.S. dollars using exchange rates as of the balance sheet date; income and expenses are translated using the weighted average exchange rates for the reporting period. Translation adjustments are recorded as accumulated other comprehensive income (loss), a separate component of stockholders’ equity.
Income Taxes	Income Taxes The Company accounts for income taxes in accordance with ASC Topic 740, Income Taxes
Net Income (Loss) Per Share	Net Income (Loss) Per Share The Company follows the provisions of ASC Topic 260, Earnings per Share Basic earnings per share is computed by dividing net income available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted earnings per share reflects the potential dilution that could occur if stock options and other commitments to issue common stock were exercised or equity awards vest resulting in the issuance of common stock or conversion of notes into shares of the Company’s common stock that could increase the number of shares outstanding and lower the earnings per share of the Company’s common stock. This calculation is not done for periods in a loss position as this would be antidilutive.
Recent Accounting Updates	Recent Accounting Updates The Company does not expect the adoption of any other recently issued accounting pronouncements to have a significant impact on its results of operations, financial position or cash flow. Updates issued but not yet adopted The Company does not expect the adoption of any other recently issued accounting pronouncements to have a significant impact on its results of operations, financial position or cash flow.

Organization and Summary of S24

Organization and Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Earnings Per Share	Years Ended December 31, 2015 December 31, 2014 Total Comprehensive Loss $ (1,621,233) $ (155,437) Denominator: Weighted average number of shares outstanding – basic and diluted 24,159,122 23,749,180 EPS: Basic and Diluted $ (0.067) $ (0.007)

Property and Equipment (Tables)

Property and Equipment (Tables)	12 Months Ended
	Dec. 31, 2015
Property, Plant and Equipment [Abstract]
Property Plant and Equipment	December 31, 2015 December 31, 2014 Estimated useful lives Computer/Office Equipment $ 454,117 $ 435,867 3-7 years Medical Equipment 2,156,820 2,123,023 3-7 years Leasehold Improvements 843,781 843,781 5-39 years Less: Accumulated Depreciation (998,224) (463,977) Net Book Value $ 2,456,494 $ 2,938,694

Business Combination (Tables)

Business Combination (Tables)	12 Months Ended
	Dec. 31, 2015
Business Combinations [Abstract]
Schedule of Purchase Price Allocation	Total PIV PIN PIC Cash $ 1,800,000 959,286 533,571 307,143 Total consideration paid $ 1,800,000 959,286 533,571 307,143
Schedule of Recognized Assets Acquired and Liabilities Assumed	Total PIV PIN PIC Fixed Assets $ 1,245,000 695,000 375,000 175,000 Goodwill 555,000 264,286 158,571 132,143 Net assets purchased $ 1,800,000 959,286 533,571 307,143
Schedule of Revenue and Gross Earnings from Acquired Assets	Year Ended December 31, 2015 Total PIV PIN PIC Revenue $ 5,035,074 1,325,993 727,237 830,983 Gross Earnings $ 1,666,746 726,596 436,112 504,038 Year Ended December 31, 2014* Total PIV PIN PIC Revenue $ 518,449 239,037 128,015 151,397 Gross Earnings $ 387,064 174,311 96,679 116,074 *For the year ended December 31, 2014, amounts included for PIV, PIN, and PIC’s revenue and gross earnings, represent two months of operations post the October 31, 2014 acquisitions date.

Goodwill (Tables)

Goodwill (Tables)	12 Months Ended
	Dec. 31, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	Balance as of January 1, 2014 $ 1,422,670 Acquisition of goodwill during the year 555,000 Changes in goodwill during the year - Balance as of December 31, 2014 1,977,670 Changes in goodwill during the year - Balance as of December 31, 2015 $ 1,977,670

Operating Lease Commitments (Ta

Operating Lease Commitments (Tables)	12 Months Ended
	Dec. 31, 2015
Leases, Operating [Abstract]
Schedule of Operating Lease Commitments	Year Total 2016 $ 379,043 2017 167,916 2018 145,866 2019 138,516 2020 138,516 Thereafter 18,000 $ 987,857

Obligations Under Capital Lea29

Obligations Under Capital Lease (Tables)	12 Months Ended
	Dec. 31, 2015
Leases, Capital [Abstract]
Schedule of Future Minimum Lease Payments for Capital Leases	Minimum Lease Payments Total 2016 $ 228,597 2017 107,740 2018 93,509 2019 83,356 2020 3,094 Total minimum lease payments 516,297 Less amount representing interest 43,411 Present value of minimum lease payments 472,886 Less current portion of minimum lease payments 205,740 Long-term capital lease obligations at December 31, 2015 $ 267,146

Promissory Notes (Tables)

Promissory Notes (Tables)	12 Months Ended
	Dec. 31, 2015
Debt Disclosure [Abstract]
Schedule of Promissory Notes	Issuance Date December 31, 2014 Balance Notes Issued Payments Unamortized Discount December 31, 2015 Balance Maturity Date 21-Mar-11 $ 20,062 $ - (12,310) $ - $ 7,752 18-Mar-16 01-Jun-14 64,937 - (64,937) - - 18-Feb-15 23-Dec-14 50,000 4,000 $ (54,000) - - On Demand 16-Jun-15 - 207,100 (61,402) (37,242) 108,456 14-Feb-17 16-Jun-15 - 147,224 (74,858) (13,785) 58,581 07-Jul-16 17-Feb-15 - 216,000 (216,000) - - 13-Apr-15 13-Mar-15 - 168,000 (168,000) - - 26-May-15 17-Apr-15 - 168,000 (168,000) - - 06-Jul-15 27-May-15 - 168,000 (168,000) - - 18-Aug-15 04-Aug-15 - 260,000 (247,000) (3,000) 10,000 05-Jan-16 22-Sep-15 - 169,000 - (44,000) 125,000 29-Feb-16 22-Dec-15 - 130,000 - (30,000) 100,000 29-Feb-16

Convertible Notes (Tables)

Convertible Notes (Tables)	12 Months Ended
	Dec. 31, 2015
Debt Disclosure [Abstract]
Schedule of Debt	Series B December 31, 2014 Balance Unamortized Discount December 31, 2015 Balance Maturity Date 03-Dec-12 $ 25,000 $ (145) $ 24,856 01-Jul-17 03-Dec-12 125,000 (1,498) 123,502 01-Jul-17 03-Dec-12 50,000 (289) 49,711 01-Jul-17 03-Dec-12 25,000 (145) 24,856 01-Jul-17 03-Dec-12 25,000 (145) 24,856 01-Jul-17 03-Dec-12 25,000 (145) 24,856 01-Jul-17 03-Dec-12 1,500,000 (8,670) 1,491,330 01-Jul-17 03-Dec-12 50,000 (289) 49,711 01-Jul-17 03-Dec-12 15,000 (87) 14,913 01-Jul-17 03-Dec-12 100,000 (387) 99,613 01-May-16 27-Mar-13 25,000 (129) 24,871 01-Sep-17 27-Mar-13 25,000 (129) 24,871 01-Sep-17 27-Mar-13 25,000 (129) 24,871 01-Sep-19 Total $ 2,015,000 $ (12,185) $ 2,002,815 Series C Issuance Date Balance at December 31, 2014 Proceeds Unamortized Discount Balance at December 31, 2015 Balance at December 31, 2015 22-May-14 $ 50,000 $ - $ (1,417) $ 48,583 31-May-17 22-May-14 22,500 - (638) 21,863 31-May-17 22-May-14 22,500 - (638) 21,863 31-May-17 25-Aug-14 50,000 - (2,095) 47,905 31-Oct-17 25-Aug-14 25,000 - (1,048) 23,952 31-Oct-17 31-Oct-14 50,000 - (1,604) 48,396 31-Oct-17 17-Feb-15 - 20,000 (751) 19,249 17-Feb-18 Total $ 220,000 $ 20,000 $ (8,190) $ 231,810 Individually Issued Issuance Date December 31, 2014 Balance Payments Unamortized Discount December 31, 2015 Balance Maturity Date 26-Mar-14 $ 300,000 $ (100,000) $ (10,625) $ 189,375 27-Feb-17
Schedule of Maturities of Long-term Debt	Series B Principal Payments 2016 $ 100,000 2017 1,890,000 2018 - 2019 25,000 Total $ 2,015,000 Series C Principal Payments 2016 $ - 2017 220,000 2018 20,000 Total $ 240,000 Individually Issued Principal Payments 2016 $ 60,000 2017 140,000 Total $ 200,000

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2015
Income Tax Disclosure [Abstract]
Schedule of Deferred Tax Assets	2015 2014 Deferred tax asset $ 1,062,352 $ 563,981 Less valuation allowance (1,062,352) (563,981) Net deferred tax asset $ - $ -
Schedule of Effective Income Tax Rate Reconciliation	2015 2014 Expected Provision (based on statutory rate) $ (551,219) $ (52,849) Increase to deferred tax valuation allowance for net operating loss carry forward 551,219 52,849 Net provision $ - $ -

Organization and Summary of S33

Organization and Summary of Significant Accounting Policies - Basic and Diluted Earners Per Share (Details) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Numerator
Total comprehensive loss	$ (1,621,233)	$ (155,437)
Denominator
Weighted average number of shares outstanding - basic and diluted	24,159,122	23,749,180
Earnings per Share
Basic earnings per share from total comprehensive income (loss)	$ (0.067)	$ (0.007)
Diluted earnings per share from total comprehensive income (loss)	$ (0.067)	$ (0.007)

Organization and Summary of S34

Organization and Summary of Significant Accounting Policies - PPE Amortization and Depreciation (Details Narrative)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Equipment
Property, Plant and Equipment [Line Items]
Property Plant and Equipment Depreciation Methods	Straight-line method
Property Plant and Equipment Useful Life	3 - 7 years
Furniture and Fixtures
Property, Plant and Equipment [Line Items]
Property Plant and Equipment Depreciation Methods	Straight-line method
Property Plant and Equipment Useful Life	5 - 7 years
Hospital Contracts
Property, Plant and Equipment [Line Items]
Property Plant and Equipment Depreciation Methods	Straight-line method
Property Plant and Equipment Useful Life	2 to 5 years
Non-compete Contract
Property, Plant and Equipment [Line Items]
Property Plant and Equipment Depreciation Methods	Straight-line method
Property Plant and Equipment Useful Life	3 - 5 years
Leasehold Improvements
Property, Plant and Equipment [Line Items]
Property Plant and Equipment Depreciation Methods	Straight-line method
Property Plant and Equipment Useful Life	5-39 years	39 years

Organization and Summary of S35

Organization and Summary of Significant Accounting Policies (Details Narrative) - USD ($)		12 Months Ended
		Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Accounts Receivable, Net, Current
Allowance for bad debts		$ 56,475	$ 64,673
Increase in allowance for Doubtful Accounts - Direct Billings		15,209	47,555
Allowance for Doubtful Accounts - Third Party Billings (Florida Operations		(275,000)	0
Increase in allowance for Doubtful Accounts - Third Party Billings (Florida Operations)		275,000	0
Goodwill and Indefinite Intangible Assets
Goodwill		1,977,670	1,977,670	$ 1,422,670
Recognized Share-Based Compensation Expense
Stock-based compensation expense, non-employees	[1]	54,933
Stock-based compensation expense, employees	[2]	93,111
Stock options granted to employees			150
Management fees		13,213
Labor expense		34,683
Other Income and (Expenses):
Foreign currency gains (losses)		(34,826)	880
Other comprehensive income (loss)		$ 119,277	14,685
SMI
Goodwill and Indefinite Intangible Assets
Goodwill			1,422,670
PIV
Goodwill and Indefinite Intangible Assets
Goodwill			264,286
PIN
Goodwill and Indefinite Intangible Assets
Goodwill			158,571
PIC
Goodwill and Indefinite Intangible Assets
Goodwill			$ 132,143
[1]	$34,683 from stock options and $20,250 from stock issued.
[2]	$47,896 from stock options, and $45,215 from stock granted.

Property and Equipment (Details

Property and Equipment (Details) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 3,454,718	$ 3,402,671
Property and equipment, accumulated depreciation	998,224	463,977
Property and equipment, net	2,456,494	2,938,694
Computer/Office Equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 454,117	$ 435,867
Property and equipment, estimated useful lives	3-7 years	3-7 years
Medical Equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 2,156,820	$ 2,123,023
Property and equipment, estimated useful lives	3-7 years	3-7 years
Leasehold Improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 843,781	$ 843,781
Property and equipment, estimated useful lives	5-39 years	39 years

Property and Equipment (Detai37

Property and Equipment (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 546,338	$ 231,955

Business Combination - Consider

Business Combination - Consideration Transfered (Details)	12 Months Ended
	Dec. 31, 2014USD ($)
Business Acquisition, Contingent Consideration [Line Items]
Cash consideration paid	$ 1,800,000
Total consideration paid	1,800,000
PIV
Business Acquisition, Contingent Consideration [Line Items]
Cash consideration paid	959,286
Total consideration paid	959,286
PIN
Business Acquisition, Contingent Consideration [Line Items]
Cash consideration paid	533,571
Total consideration paid	533,571
PIC
Business Acquisition, Contingent Consideration [Line Items]
Cash consideration paid	307,143
Total consideration paid	$ 307,143

Business Combination - Recogniz

Business Combination - Recognized Identifiable Assets Acquired and Liabilities Assumed (Details)	Dec. 31, 2014USD ($)
Business Acquisition [Line Items]
Fair value fixed assets	$ 1,245,000
Fair value goodwill	555,000
Fair value net assets purchased	1,800,000
PIV
Business Acquisition [Line Items]
Fair value fixed assets	695,000
Fair value goodwill	264,286
Fair value net assets purchased	959,286
PIN
Business Acquisition [Line Items]
Fair value fixed assets	375,000
Fair value goodwill	158,571
Fair value net assets purchased	533,571
PIC
Business Acquisition [Line Items]
Fair value fixed assets	175,000
Fair value goodwill	132,143
Fair value net assets purchased	$ 307,143

Business Combination - Revenue

Business Combination - Revenue and Gross Earnings (Details) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	[1]
Business Acquisition [Line Items]
Revenue from business combination	$ 5,035,074	$ 518,449
Gross Earnings from business combination	1,666,746	387,064
PIV
Business Acquisition [Line Items]
Revenue from business combination	1,325,993	239,037
Gross Earnings from business combination	726,596	174,311
PIN
Business Acquisition [Line Items]
Revenue from business combination	727,237	128,015
Gross Earnings from business combination	436,112	96,679
PIC
Business Acquisition [Line Items]
Revenue from business combination	830,983	151,397
Gross Earnings from business combination	$ 504,038	$ 116,074
[1]	For the year ended December 31, 2014, amounts included for PIV, PIN, and PIC's revenue and gross earnings, represent two months of operations post the October 31, 2014 acquisitions date.

Business Combination (Details N

Business Combination (Details Narrative)	12 Months Ended
	Dec. 31, 2014USD ($)
Business Combinations [Abstract]
Date of acquisition	Oct. 31, 2014
Name of Acquired Entities	Partners Imaging Center of Venice, LLC (PIV), Partners Imaging Center of Naples, LLC (PIN) and Partners Imaging Center of Charlotte, LLC (PIC)
Equity interest acquired, percent	100.00%
Share Purchase Agreement, purchase price	$ 1,800,000
Business combination, costs related to the acquisition	29,500
Business combination, goodwill	$ 555,000

Goodwill (Details)

Goodwill (Details) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Goodwill [Roll Forward]
Goodwill, balance at beginning of period	$ 1,977,670	$ 1,422,670
Changes in Goodwill	0	0
Goodwill, Acquired During Period	0	555,000
Goodwill, balance at end of period	$ 1,977,670	$ 1,977,670

Operating Lease Commitments (De

Operating Lease Commitments (Details)	Dec. 31, 2015USD ($)
Leases, Operating [Abstract]
Year 2,016	$ 379,043
Year 2,017	167,916
Year 2,018	145,866
Year 2,019	138,516
Year 2,020	138,516
Thereafter	18,000
Operating Leases, Future Minimum Payments Due	$ 987,857

Operating Lease Commitments (44

Operating Lease Commitments (Details Narrative)	12 Months Ended
	Dec. 31, 2015USD ($)
CTS - Office Space
Operating lease, minimum payments	$ 6,000
Leasing arrangements	CTS has a lease commitment for its office space of approximately $2,450 minimum rental, and approximately $3,550 in utilities, realty taxes, and operating costs. The Lease renewed in April 2013 for a period of five years and will expire in March 2018.
Rental credit	$ 28,000
SMI - Office Space - Pottsville, Pennsylvania
Operating lease, minimum payments	$ 7,111
Leasing arrangements	SMI entered into a lease commitment for its office space in Pottsville, Pennsylvania. The lease will expire on June 30, 2016, and it is renewable for an additional term of 5 years on the same terms and conditions.
SMI - X-Ray Equipment
Operating lease, minimum payments	$ 2,000
Leasing arrangements	The lease term is seven years from commitment date of October 2014
SMI - Office Space - Dallas, Texas
Operating lease, minimum payments	$ 880
Leasing arrangements	SMI has a lease for office space that will expire in August 31, 2016.
Lease Arrangement | PIC
Operating lease, minimum payments	$ 5,512
Leasing arrangements	PIC has a lease for office space in Port Charlotte, Florida. The lease will expire June 20, 2016.
Lease Arrangement | PIN
Operating lease, minimum payments	$ 9,543
Leasing arrangements	PIN has a lease for office space in Naples, Florida. The lease will expire January 1, 2020.
Lease Arrangement | PIV
Operating lease, minimum payments	$ 15,377
Leasing arrangements	PIV has a lease for office space in Venice, Florida. The lease will expire October 1, 2016.

Obligations Under Capital Lea45

Obligations Under Capital Lease (Details) - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Capital Leases Future Minimum Payments
Minimum future lease payments, 2016	$ 228,597
Minimum future lease payments, 2017	107,740
Minimum future lease payments, 2018	93,509
Minimum future lease payments, 2019	83,356
Minimum future lease payments, 2020	3,094
Total minimum lease payments	516,297
Less amount representing interest	43,411
Present value of minimum lease payments	472,886
Less current portion of minimum lease payments	205,740	$ 189,923
Obligations Under Capital Lease, long term portion	$ 267,146	$ 459,853

Obligations Under Capital Lea46

Obligations Under Capital Lease (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
SMI - MRI
Capital Leased Assets [Line Items]
Capital leases, equipment, gross	$ 555,000
Capital leases, equipment, net	218,833	$ 323,833
Capital leases, depreciation expense	111,000	111,000
Capital leases, accumulated amortization and depreciation	$ 342,167	231,167
Capital leases, leasing arrangements	On December 10, 2012, the Company entered into a lease agreement with one of the sellers of SMI to lease the two MRI machines. Under the terms of the lease, SMI is to make monthly payments of $11,013, plus applicable sales tax, over a period of 48 months. In addition, SMI agreed to make a one-time lease payment of $125,000, which was paid by March 30, 2013. The Company has guaranteed all of SMI’s obligations under the lease. At the end of the lease, SMI will have the option to purchase the MRI machines for a total purchase price of $1.00.
SMI - X-Ray Lease
Capital Leased Assets [Line Items]
Capital leases, equipment, gross	$ 78,250
Capital leases, equipment, net	54,775	70,425
Capital leases, depreciation expense	15,650	7,825
Capital leases, accumulated amortization and depreciation	$ 23,475	7,825
Capital leases, leasing arrangements	On July 03, 2014 Company has entered into a capital lease agreement to lease the x-ray machine that was delivered and installed in July 2014. Under the terms of the lease, the Company’s subsidiary, SMI, is to make monthly payments of $1,495, plus applicable sales tax, over a period of 60 months. At the end of the lease, SMI will have the option to purchase the MRI machines for a total purchase price of $1.00.
SMI - PACS/RIS Lease
Capital Leased Assets [Line Items]
Capital leases, equipment, gross	$ 162,333
Capital leases, equipment, net	124,455	156,922
Capital leases, depreciation expense	32,467	5,411
Capital leases, accumulated amortization and depreciation	$ 37,878	5,411
Capital leases, leasing arrangements	On August 19, 2014 Company has entered into a capital lease agreement to lease PACS/RIS system that was delivered and installed in December 2014. Under the terms of the lease, the Company’s subsidiary, SMI, is to make monthly payments of $3,115, plus applicable sales tax, over a period of 60 months. At the end of the lease, SMI will have the option to purchase the system for a total purchase price of $1.00.
PV, PN, PC PACS/RIS Lease
Capital Leased Assets [Line Items]
Capital leases, equipment, gross	$ 167,107
Capital leases, equipment, net	132,292	165,714
Capital leases, depreciation expense	33,422	1,393
Capital leases, accumulated amortization and depreciation	$ 34,815	1,393
Capital leases, leasing arrangements	On November 26, 2014 Company has entered into a capital lease agreement to lease PACS/RIS system that was delivered and installed in December 2014. Under the terms of the lease, the Company’s subsidiary, PIV, is to make monthly payments of $3,094, plus applicable sales tax, over a period of 60 months. At the end of the lease, PIV will have the option to purchase the system for a total purchase price of $1.00.
PV, PN, PC Computers Lease
Capital Leased Assets [Line Items]
Capital leases, equipment, gross	$ 25,108
Capital leases, equipment, net	16,390	24,759
Capital leases, depreciation expense	8,369	349
Capital leases, accumulated amortization and depreciation	$ 8,718	$ 349
Capital leases, leasing arrangements	On December 10, 2014 Company has entered into a capital lease agreement to lease computers that were delivered and installed in December 2014. Under the terms of the lease, the Company is to make monthly payments of $813, plus applicable sales tax, over a period of 36 months. At the end of the lease, the company will have the option to purchase the computers for a total purchase price of $1.00.
CTS Computers Lease
Capital Leased Assets [Line Items]
Capital leases, equipment, gross	$ 18,997
Capital leases, equipment, net	12,767
Capital leases, depreciation expense	5,617
Capital leases, accumulated amortization and depreciation	$ 6,230
Capital leases, leasing arrangements	On January 21, 2015 the company has entered into a capital lease agreement to lease computers that were installed on the same date of acceptance. Under the terms of the lease, the company is to make monthly payments of $529, plus applicable sales tax, over a period of 36 months. At the end of the lease, the company will have the option to purchase the computers for a total purchase price of $1.00.

Promissory Notes (Details)

Promissory Notes (Details)	12 Months Ended
	Dec. 31, 2015USD ($)
Short-term Debt [Line Items]
Promissory notes, beginning of period	$ 134,999
Notes issued	1,637,324
Payments	(1,234,507)
Unamortized discount	(128,027)
Promissory notes, end of period	$ 409,789
Promissory Note #1
Short-term Debt [Line Items]
Promissory note, issuance date	Mar. 21, 2011
Promissory notes, beginning of period	$ 20,062
Payments	(12,310)
Promissory notes, end of period	$ 7,752
Promissory note, maturity date	Mar. 18, 2016
Promissory Note #2
Short-term Debt [Line Items]
Promissory note, issuance date	Jun. 1, 2014
Promissory notes, beginning of period	$ 64,937
Payments	(64,937)
Promissory notes, end of period	$ 0
Promissory note, maturity date	Feb. 18, 2015
Promissory Note #3
Short-term Debt [Line Items]
Promissory note, issuance date	Dec. 23, 2014
Promissory notes, beginning of period	$ 50,000
Notes issued	4,000
Payments	(54,000)
Promissory notes, end of period	$ 0
Promissory note, maturity date, description	On Demand
Promissory Note #4
Short-term Debt [Line Items]
Promissory note, issuance date	Jun. 16, 2015
Promissory notes, beginning of period	$ 0
Notes issued	207,100
Payments	(61,402)
Unamortized discount	(37,242)
Promissory notes, end of period	$ 108,456
Promissory note, maturity date	Feb. 14, 2017
Promissory Note #5
Short-term Debt [Line Items]
Promissory note, issuance date	Jun. 16, 2015
Promissory notes, beginning of period	$ 0
Notes issued	147,224
Payments	(74,858)
Unamortized discount	(13,785)
Promissory notes, end of period	$ 58,581
Promissory note, maturity date	Jul. 7, 2016
Promissory Note #6
Short-term Debt [Line Items]
Promissory note, issuance date	Feb. 17, 2015
Promissory notes, beginning of period	$ 0
Notes issued	216,000
Payments	(216,000)
Promissory notes, end of period	$ 0
Promissory note, maturity date	Apr. 13, 2015
Promissory Note #7
Short-term Debt [Line Items]
Promissory note, issuance date	Mar. 13, 2015
Promissory notes, beginning of period	$ 0
Notes issued	168,000
Payments	(168,000)
Promissory notes, end of period	$ 0
Promissory note, maturity date	May 26, 2015
Promissory Note #8
Short-term Debt [Line Items]
Promissory note, issuance date	Apr. 17, 2015
Promissory notes, beginning of period	$ 0
Notes issued	168,000
Payments	(168,000)
Promissory notes, end of period	$ 0
Promissory note, maturity date	Jul. 6, 2015
Promissory Note #9
Short-term Debt [Line Items]
Promissory note, issuance date	May 27, 2015
Promissory notes, beginning of period	$ 0
Notes issued	168,000
Payments	(168,000)
Promissory notes, end of period	$ 0
Promissory note, maturity date	Aug. 18, 2015
Promissory Note #10
Short-term Debt [Line Items]
Promissory note, issuance date	Aug. 4, 2015
Promissory notes, beginning of period	$ 0
Notes issued	260,000
Payments	(247,000)
Unamortized discount	(3,000)
Promissory notes, end of period	$ 10,000
Promissory note, maturity date	Jan. 5, 2016
Promissory Note #11
Short-term Debt [Line Items]
Promissory note, issuance date	Sep. 22, 2015
Promissory notes, beginning of period	$ 0
Notes issued	169,000
Unamortized discount	(44,000)
Promissory notes, end of period	$ 125,000
Promissory note, maturity date	Feb. 29, 2016
Promissory Note #12
Short-term Debt [Line Items]
Promissory note, issuance date	Dec. 22, 2015
Promissory notes, beginning of period	$ 0
Notes issued	130,000
Unamortized discount	(30,000)
Promissory notes, end of period	$ 100,000
Promissory note, maturity date	Feb. 29, 2016

Promissory Notes (Details Narra

Promissory Notes (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Promissory note, additional proceeds	$ 1,637,324
Repayment of debt	1,234,507
Promissory Notes
Promissory note, additional proceeds	$ 1,633,324
Short term loan payable, repayment terms	The loans totaling $720,000 terms call for total weekly payments of $28,000 towards the principal balance and interest. The loans were collateralized by the Accounts Receivable of PIV, PIN, and PIC. The final payment was due August 18, 2015. The loans were paid in full by the maturity date. The loans totaling $559,000 call for weekly payments of $13,000 towards the principal balance and interest. The loans were collateralized by the Accounts Receivable of PIV, PIN, and PIC. The notes were paid off early on February 29, 2016. The early pay off resulted in a saving of $20,000 in interest. The loans totaling $207,100 call for a daily payment of $509, towards the principal balance and interest. The final payment is due February 14, 2017. The loans are collateralized by the Accounts Receivable of: SMI, PIV, PIN, and PIC. The loan totaling $147,224 call for a daily payment of $553, towards the principal balance and interest. The loans were collateralized by the Accounts Receivable of: CTS SMI, PIV, PIN, and PIC.
Promissory Notes | SMI
Promissory note, assigned		$ (64,937)
Promissory note, interest rate		12.00%
Promissory note, maturity date		Feb. 1, 2015
Repayment of debt	$ 64,937
Promissory Notes | Non-Related Party
Promissory note, additional proceeds	4,000	$ 50,000
Repayment of debt	$ 54,000

Convertible Notes - Details of

Convertible Notes - Details of Series B Notes (Details) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Debt Instrument [Line Items]
Convertible note, amortization of debt discount	$ (613,121)	$ (116,904)
Convertible Notes | Series B - Note 8
Debt Instrument [Line Items]
Convertible note, issuance date	Dec. 3, 2012
Convertible note, beginning balance	$ 50,000
Convertible note, unamortized debt discount	(289)
Convertible note, ending balance	$ 49,711	50,000
Convertible note, maturity date	Jul. 1, 2017
Convertible Notes | Series B - Note 7
Debt Instrument [Line Items]
Convertible note, issuance date	Dec. 3, 2012
Convertible note, beginning balance	$ 1,500,000
Convertible note, unamortized debt discount	(8,670)
Convertible note, ending balance	$ 1,491,330	1,500,000
Convertible note, maturity date	Jul. 1, 2017
Convertible Notes | Series B - Note 6
Debt Instrument [Line Items]
Convertible note, issuance date	Dec. 3, 2012
Convertible note, beginning balance	$ 25,000
Convertible note, unamortized debt discount	(145)
Convertible note, ending balance	$ 24,856	25,000
Convertible note, maturity date	Jul. 1, 2017
Convertible Notes | Series B - Note 5
Debt Instrument [Line Items]
Convertible note, issuance date	Dec. 3, 2012
Convertible note, beginning balance	$ 25,000
Convertible note, unamortized debt discount	(145)
Convertible note, ending balance	$ 24,856	25,000
Convertible note, maturity date	Jul. 1, 2017
Convertible Notes | Series B - Note 4
Debt Instrument [Line Items]
Convertible note, issuance date	Dec. 3, 2012
Convertible note, beginning balance	$ 25,000
Convertible note, unamortized debt discount	(145)
Convertible note, ending balance	$ 24,856	25,000
Convertible note, maturity date	Jul. 1, 2017
Convertible Notes | Series B - Note 3
Debt Instrument [Line Items]
Convertible note, issuance date	Dec. 3, 2012
Convertible note, beginning balance	$ 50,000
Convertible note, unamortized debt discount	(289)
Convertible note, ending balance	$ 49,711	50,000
Convertible note, maturity date	Jul. 1, 2017
Convertible Notes | Series B - Note 2
Debt Instrument [Line Items]
Convertible note, issuance date	Dec. 3, 2012
Convertible note, beginning balance	$ 125,000
Convertible note, unamortized debt discount	(1,498)
Convertible note, ending balance	$ 123,502	125,000
Convertible note, maturity date	Jul. 1, 2017
Convertible Notes | Series B - Note 1
Debt Instrument [Line Items]
Convertible note, issuance date	Dec. 3, 2012
Convertible note, beginning balance	$ 25,000
Convertible note, unamortized debt discount	(145)
Convertible note, ending balance	$ 24,856	$ 25,000
Convertible note, maturity date	Jul. 1, 2017

Convertible Notes - Details o50

Convertible Notes - Details of Series B Notes Continued (Details) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Debt Instrument [Line Items]
Convertible note, amortization of debt discount	$ (613,121)	$ (116,904)
Convertible Notes | Series B - Note 13
Debt Instrument [Line Items]
Convertible note, issuance date	Mar. 27, 2013
Convertible note, beginning balance	$ 25,000
Convertible note, unamortized debt discount	(129)
Convertible note, ending balance	$ 24,871	25,000
Convertible note, maturity date	Sep. 1, 2019
Convertible Notes | Series B - Note 12
Debt Instrument [Line Items]
Convertible note, issuance date	Mar. 27, 2013
Convertible note, beginning balance	$ 25,000
Convertible note, unamortized debt discount	(129)
Convertible note, ending balance	$ 24,871	25,000
Convertible note, maturity date	Sep. 1, 2017
Convertible Notes | Series B - Note 11
Debt Instrument [Line Items]
Convertible note, issuance date	Mar. 27, 2013
Convertible note, beginning balance	$ 25,000
Convertible note, unamortized debt discount	(129)
Convertible note, ending balance	$ 24,871	25,000
Convertible note, maturity date	Sep. 1, 2017
Convertible Notes | Series B - Note 10
Debt Instrument [Line Items]
Convertible note, issuance date	Dec. 3, 2012
Convertible note, beginning balance	$ 100,000
Convertible note, unamortized debt discount	(387)
Convertible note, ending balance	$ 99,613	100,000
Convertible note, maturity date	May 1, 2016
Convertible Notes | Series B - Note 9
Debt Instrument [Line Items]
Convertible note, issuance date	Dec. 3, 2012
Convertible note, beginning balance	$ 15,000
Convertible note, unamortized debt discount	(87)
Convertible note, ending balance	$ 14,913	$ 15,000
Convertible note, maturity date	Jul. 1, 2017

Convertible Notes - Details o51

Convertible Notes - Details of Series C and Individually Issued Notes (Details) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Debt Instrument [Line Items]
Convertible note, amortization of debt discount	$ (613,121)	$ (116,904)
Convertible Notes | Individually Issued
Debt Instrument [Line Items]
Convertible note, issuance date	Mar. 26, 2014
Convertible note, beginning balance	$ 300,000
Convertible note, accrued interest	27,884
Convertible note, payments	(100,000)
Convertible note, amortization of debt discount	(8,500)
Convertible note, unamortized debt discount	(10,625)
Convertible note, ending balance	$ 189,375	300,000
Convertible note, maturity date	Feb. 27, 2017
Convertible Notes | Series C - Note 7
Debt Instrument [Line Items]
Convertible note, issuance date	Feb. 17, 2015
Convertible note, beginning balance	$ 0
Convertible note, proceeds	20,000
Convertible note, unamortized debt discount	(751)
Convertible note, ending balance	$ 19,249	0
Convertible note, maturity date	Feb. 17, 2018
Convertible Notes | Series C - Note 6
Debt Instrument [Line Items]
Convertible note, issuance date	Oct. 31, 2014
Convertible note, beginning balance	$ 50,000
Convertible note, unamortized debt discount	(1,604)
Convertible note, ending balance	$ 48,396	50,000
Convertible note, maturity date	Oct. 31, 2017
Convertible Notes | Series C - Note 5
Debt Instrument [Line Items]
Convertible note, issuance date	Aug. 25, 2014
Convertible note, beginning balance	$ 25,000
Convertible note, unamortized debt discount	(1,048)
Convertible note, ending balance	$ 23,952	25,000
Convertible note, maturity date	Oct. 31, 2017
Convertible Notes | Series C - Note 4
Debt Instrument [Line Items]
Convertible note, issuance date	Aug. 25, 2014
Convertible note, beginning balance	$ 50,000
Convertible note, unamortized debt discount	(2,095)
Convertible note, ending balance	$ 47,905	50,000
Convertible note, maturity date	Oct. 31, 2017
Convertible Notes | Series C - Note 3
Debt Instrument [Line Items]
Convertible note, issuance date	May 22, 2014
Convertible note, beginning balance	$ 22,500
Convertible note, unamortized debt discount	(638)
Convertible note, ending balance	$ 21,863	22,500
Convertible note, maturity date	May 31, 2017
Convertible Notes | Series C - Note 2
Debt Instrument [Line Items]
Convertible note, issuance date	May 22, 2014
Convertible note, beginning balance	$ 22,500
Convertible note, unamortized debt discount	(638)
Convertible note, ending balance	$ 21,863	22,500
Convertible note, maturity date	May 31, 2017
Convertible Notes | Series C - Note 1
Debt Instrument [Line Items]
Convertible note, issuance date	May 22, 2014
Convertible note, beginning balance	$ 50,000
Convertible note, unamortized debt discount	(1,417)
Convertible note, ending balance	$ 48,583	$ 50,000
Convertible note, maturity date	May 31, 2017

Convertible Notes - Long-Term D

Convertible Notes - Long-Term Debt Maturities (Details) - Convertible Notes	Dec. 31, 2015USD ($)
Individually Issued
Debt Instrument [Line Items]
Principal payments, 2016	$ 60,000
Principal payments, 2017	140,000
Total principal payments	200,000
Series C Notes
Debt Instrument [Line Items]
Principal payments, 2017	220,000
Principal payments, 2018	20,000
Total principal payments	240,000
Series B Notes
Debt Instrument [Line Items]
Principal payments, 2016	100,000
Principal payments, 2017	1,890,000
Principal payments, 2019	25,000
Total principal payments	$ 2,015,000

Convertible Notes (Details Narr

Convertible Notes (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Amortization of debt discount	$ 613,121	$ 116,904
Convertible Notes | Individually Issued
Convertible notes, sold		$ 300,000
Convertible notes, payment terms		The note pays interest at a rate of 12% per annum, payable to the holder at 1% per month. The Company will also be making monthly payments of $5,000 towards the principal balance beginning June 1, 2014 for 3 years until the note due date of February 27, 2017.
Convertible notes, price per share for conversion of shares of common stock		$ 0.15
Convertible notes, interest rate		12.00%
Note holder additions		The non-affiliate will receive 300,000 shares as part of the note agreement.
Additional paid in capital and discount	25,500
Amortization of debt discount	8,500
Convertible note, accrued interest	27,884
Private placement, maturity date		Feb. 27, 2017
Common stock issued		300,000
Convertible Notes | Series C Notes
Convertible notes, sold	20,000	$ 125,000
Convertible notes, payment terms		Series C Notes bear interest at a rate of 12% per annum, payable to the holder at 1% per month, with principal amount due May 31, 2017.
Convertible notes, price per share for conversion of shares of common stock		$ 0.15
Convertible notes, interest rate		12.00%
Additional paid in capital and discount	12,695
Amortization of debt discount	5,049
Convertible note, accrued interest	$ 28,400
Private placement, 12% convertible notes, principal amount		$ 95,000
Private placement, maturity date		May 31, 2017
Common stock issued	240,000
Convertible Notes | Series B Notes
Convertible notes, payment terms			Series B Notes pay interest at a rate of 12% per annum, payable to the holder at 1% per month.
Convertible notes, price per share for conversion of shares of common stock			$ 0.15
Convertible notes, interest rate			12.00%
Additional paid in capital and discount	$ 244,275
Amortization of debt discount	75,156	$ 81,425
Convertible note, accrued interest	241,800
Interest paid	$ 226,800
Private placement, 12% convertible notes, principal amount			$ 2,230,000
Private placement, maturity date, description	The holders of $1,840,000 Series B Notes have agreed to extend the maturity date of the debt outstanding to July 1, 2017 from its original maturity date of December 31, 2015.
Private placement, maturity date	Jul. 1, 2017
Common stock issued			5,315,000
Warrants issued, shares	1,840,000
Warrants issued, value per share	$ 0.07
Exercise price	$ 0.0058
Unamortized debt discount	$ 10,672

Royalty Financing (Details Narr

Royalty Financing (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Royalty Financing
Royalty purchase agreement		On October 31, 2014, the Company entered into a royalty purchase agreement with Grenville Strategic Royalty Corp. for the amount of $2,000,000. The agreement calls for a monthly payment to the seller based on a percentage of the total of certain revenue items and subject to a minimum payment amount.
Royalty payments	$ 410,189	$ 0
Discounted amortization expense	340,372	$ 40,948
Accrued royalties	1,935,101
Royalty financing, unamortized discount	$ 5,618,680

Income Taxes - Deferred Taxes (

Income Taxes - Deferred Taxes (Details) - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Deferred tax asset	$ 1,062,352	$ 563,981
Less valuation allowance	(1,062,352)	(563,981)
Net deferred tax asset	$ 0	$ 0

Income Taxes - Effective Income

Income Taxes - Effective Income Tax Rate Reconciliation (Details) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Expected Provision (based on statutory rate)	$ (551,219)	$ (52,849)
Increase to deferred tax valuation allowance for net operating loss carry forward	551,219	52,849
Net provision	$ 0	$ 0

Income Taxes (Details Narrative

Income Taxes (Details Narrative)	12 Months Ended
	Dec. 31, 2015USD ($)
Income Tax Disclosure [Abstract]
Operating loss carryforward	$ 1,621,233
Operating loss carryforward, expiration	Dec. 31, 2017
Income taxes at statutory tax rates	34.00%
Income tax payable	$ 16,480
Income tax credit	43,311
Income tax payments	$ 33,380

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Common stock issued for services, value	$ 65,465	$ 150
Major Shareholder
Consulting services, description	January 2015, the Company entered into an agreement with a company that is owned and controlled by a major shareholder, to provide consulting services. Fees payable for performance of the consulting services are $10,000 per month.
Stock options, granted	4,200,000
Stock options, exercise price	$ 0.15
Stock options, contractual term	2 years 6 months
Common stock issued for services	450,000
Common stock issued for services, value	$ 20,250
Balance for services rendered	$ 8,513

Common Stock Transactions (Deta

Common Stock Transactions (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Convertible Notes | Individually Issued
Shares issued, convertible notes, shares		300,000
Shares issued, convertible notes, value		$ 25,500
Convertible Notes | Series C Notes
Shares issued, convertible notes, shares	20,000	220,000
Shares issued, convertible notes, value	$ 1,040	$ 14,280
Convertible Notes | Series B Notes
Warrants issued, shares	1,840,000
Warrants issued, value per share	$ 0.07
Exercise price	$ 0.0058
Common Stock
Shares issued for services, shares	1,425,000	5,000
Shares issued for services, value	$ 65,465	$ 150
Major Shareholder
Stock options, granted	4,200,000
Stock options, exercise price	$ 0.15
Stock options, contractual term	2 years 6 months
Stock price at grant date	$ 0.0517
Expected volatility rate	70.00%
Risk free interest rate	0.03%
Value of stock options at grant date	$ 34,683
Shares issued for services, shares	450,000
Shares issued for services, value	$ 20,250
Chief Executive Officer
Stock options, granted	4,200,000
Stock options, exercise price	$ 0.15
Stock options, contractual term	2 years 6 months
Stock price at grant date	$ 0.0517
Expected volatility rate	70.00%
Risk free interest rate	0.03%
Value of stock options at grant date	$ 34,683
Chief Financial Officer
Stock options, granted	1,600,000
Stock options, exercise price	$ 0.15
Stock options, contractual term	2 years 6 months
Stock price at grant date	$ 0.0517
Expected volatility rate	70.00%
Risk free interest rate	0.03%
Value of stock options at grant date	$ 13,213

Going Concern (Details Narrativ

Going Concern (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Going Concern
Total Comprehensive Income (Loss)	$ (1,621,233)	$ (155,437)
Working capital deficit	$ 1,646,533

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - USD ($)	1 Months Ended		12 Months Ended
	Mar. 31, 2016	Feb. 29, 2016	Dec. 31, 2015	Dec. 31, 2014
Subsequent Event [Line Items]
Proceeds from convertible note			$ 20,000	$ 495,000
Repayment of debt			$ 1,234,507
Subsequent Event | Convertible Notes
Subsequent Event [Line Items]
Interest rate		25.00%
Proceeds from convertible note		$ 500,000
Security interest, description		The Holder will maintain a security interest in the Company until such time as the Note is retired, the Company raises $1,200,000 in additional capital, or the Note is converted into the Royalty.
Subsequent Event | Bridge Note
Subsequent Event [Line Items]
Bridge loan	$ 70,000	$ 100,000
Interest rate	12.00%	12.00%
Shares issued, inducement	70,000	100,000
Bridge loan, maturity date	Mar. 22, 2017	Feb. 23, 2017
Subsequent Event | Promissory Notes
Subsequent Event [Line Items]
Repayment of debt	$ 58,581	$ 235,000
Decrease in interest payable		$ (20,000)